Thyroid, infection drugs get fresh safety warnings after national review
Times of India
by ANUJA JAISWALFebruary 19, 2026
AI-Generated Deep Dive Summary
After a comprehensive national review, India has decided to strengthen safety warnings for two widely used medications: doxycycline, an antibiotic, and carbimazole, a thyroid treatment. This decision was made following the analysis of adverse drug reaction reports and patient-level data, which identified previously unreported side effects.
Doxycycline, commonly prescribed for infections like respiratory diseases, acne, and sexually transmitted infections, will now include warnings about potential mental health symptoms such as restlessness, anxiety, irritability, nervousness, and dizziness. These findings were reviewed by the Pharmacovigilance Programme of India and endorsed by the Subject Expert Committee on antimicrobial drugs.
Carbamazol
Verticals
worldasia
Originally published on Times of India on 2/19/2026